• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Drug Policy and Law
  • Harm Reduction
  • Activism

Drugreporter

News and Films from the Frontline of the War on Drugs

  • News
  • Café
  • Videos
  • About Us
  • EN
    • HU
    • RU

The Psychedelic Science Frontier

April 23, 2019 | Author: Péter Sárosi

Tweet

Inspired by the testimony of a psychedelic fungi grower, we went to the Czech National Mental Health Institute in the Czech Republic to meet the scientists making psychedelics legal. A movie produced by Polish members of our global video advocacy network.

Largely unnoticed, a major paradigm shift is happening in the field of mental health. With data showing that every 6th person on the planet already has either experienced some sort of psychological issue, is experiencing one now, or will be in the future, mental health is clearly one of the most burning challenges of today. There has been a long overstated dogma: that all antidepressant drugs need weeks, if not months, to work. This is about to change forever with psychedelic (hallucinogenic) compounds making their way into mainstream medicine.

LSD (“acid”), DMT (“ayahuasca”) or psilocybin (“magic mushrooms”) are all currently scheduled by law in a category “with no medical use and high addiction potential”. Despite their illegal status, millions of people continue to use these (and dozens more) psychedelics for various reasons all around the world. Some enjoy them in recreational settings, some in a spiritual context, while others call hallucinogens their “private medicine”. We met in Warsaw with one of the latter, a clandestine psychedelic mushroom grower, and learned how he perceives the Psilocybe Cubensis fungi helped him grow personally.

Inspired by this testimony, we set out to learn more about the much-hyped medical potential of psychedelics. We went to the Czech Republic to meet with the Czech Psychedelic Society (CZEPS) and a group of scientists from the Czech National Mental Health Institute (NUDZ) in Klecany near Prague. Together they work on psychedelic research and recently set up another body, the PsyRes Foundation. The Psychedelic Research (PsyRes) Foundation was set up to help facilitate funding for innovative projects, such as a trip to the Amazon to study ayahuasca in traditional settings, or an app for people who use psychedelics.

Why focus on psychedelics research? For psychiatrists in the Klecany institute, it is simple. They work with patients with treatment resilient depression who have tried every classic antidepressant on the market but are still horribly, chronically depressed. That is why the scientists try many experimental treatments, such as transcranial magnetic stimulation, even electrical current stimulation and, last but not least, hallucinogenic drugs, said team leader Dr. Martin Brunovský Ph.D.

“Psychedelics work biologically,” elaborated his colleague Dr. Veronika Andrashko, who works with ketamine assisted treatment. Both ketamine, as the most established treatment, and classic psychedelics, show signs of synaptogenesis in the brain – the making of new synapses, new connections. “The changes that we see in the brains of ketamine patients are similar to what we see after 2 weeks of successful antidepressant therapy”, Dr. Andrashko explained.

But it’s not all in the drugs. Czech researchers prefer to focus on psychedelic-assisted psychotherapy. Dr. Filip Tylš Ph.D., who works mainly with psilocybin, reminds us of the words of legendary Czech scientist, Prof. Stanislav Grof, who oversaw over 4,500 LSD sessions: “psychedelics are nonspecific amplifiers”. Whatever a patient experiences it will be amplified under influence, therefore it’s especially effective to pair hallucinogenic drugs with psychotherapy.

The experiments are nothing like those from the hippy 1960s. For now, researchers try to learn how to predict if someone might benefit from psychedelics – or if it could end up being a traumatic experience. The research is tightly regulated, from licensing, through meticulous monitoring, to the extreme costs that come with all this bureaucracy. PsyRes Foundation scientists want to bring psychedelic-assisted treatment to a psychiatrist near you, but need help to make progress. By going to the website http://psyresfoundation.eu anyone can donate and also choose what research they would like their funding to go to. Which psychedelic-assisted treatment would you like to see first: ketamine, psilocybin, LSD, or DMT?

Jerzy Afanajew and Sebastian Walczak

Filed Under: Articles, Drugreporter Video Advocacy Network, Video Database Topics: Psychedelic Medicines

Access to this article is free - but to produce articles and videos is not. Drugreporter is a non-profit website that needs your support to provide you with high quality contents.

Become a supporter and make a donation of 5 $ today!

Kapcsolódó cikkek:

Psychedelics and Mental Health in the COVID-Era

September 7, 2020 - Péter Sárosi

Beyond the Medicalisation of Psychedelics – An Interview with Levente Móró

September 17, 2019 - Jonathan Brozdowski

International Harm Reduction Film Festival 2019: Final Programme

April 25, 2019 - Péter Sárosi

Kapcsolódó videók:

Decriminalisation in Portugal: Through the Lens of People who Use Drugs

December 5, 2022 - István Gábor Takács

Drugreporter News | 2022 November

November 24, 2022 - István Gábor Takács

Harm Reduction in Athens – With the Eye of an Outsider

November 23, 2022 - Péter Sárosi

You can browse our topics here:

Activism COVID-19 Criminalisation Dose of Science Drug Consumption Rooms Drug Policy and Law European Drug Policy Harm Reduction Hepatitis HIV/AIDS Marijuana Policies Medical Marijuana Needle and syringe programs New Psychoactive Substances Opiate Substitution Overdose Prevention Psychedelic Medicines Regulation and Control Russian Drug Policy Sex Work United Nations Drug Policy US Drug Policy

Primary Sidebar

BECOME A SUPPORTER OF DRUGREPORTER! INVEST THE PRICE OF A COFFEE MONTHLY AND MAKE SURE DRUGREPORTER KEEPS RUNNING!
Subscribe to the Newsletter!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
  • Facebook
  • Twitter
  • YouTube

Search

Drugreporter Video Database

Hundreds of videos on drug policy, harm reduction and human rights for streaming and download, also on a world map!

DRUGREPORTER NEWS

Monthly drug policy news from around the world

Drugreporter café

In our new online video show, we regularly discuss new developments in the world of drug policy with professionals, activists and decision makers. You can also listen to the Drugreporter Café in Podcast format on Spotify or Apple Podcasts!

COVID-19 Harm Reduction Update

On this info page Drugreporter provides regular updates about resources and news on how harm reduction service providers respond to the COVID-19 Epidemic.

Drugreporter Video Advocacy Network

Browse videos produced by members of our Drugreporter Video Advocacy Network, from all around the world!

DRUG USERS NEWS

Russian language videos on drug policy, harm reduction and human rights.

Our award winning animated documentary movie is based on the original audio recording of Kostya Proletarsky, a drug user and HIV activist who died as a result of mistreatment and torture at a Russian prison. Festival appearances, news and resources are available here!

Footer

Rights Reporter Foundation
Hungary, 1032 Budapest
San Marco Street 70.
Email: rightsreporter@rightsreporter.net

Search

Our other websites:

The Rights Reporter Foundation

The Autocracy Analyst

Room for Change Campaign

Room in the 8th District Campaign

A Day in the Life movie website

Drugreporter